Tidal Investments’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $880K | Sell |
3,646
-16
| -0.4% | -$3.86K | 0.01% | 1068 |
|
|
2025
Q1 | $892K | Buy |
3,662
+2,593
| +243% | +$632K | 0.01% | 996 |
|
|
2024
Q4 | $351K | Buy |
1,069
+186
| +21% | +$61.1K | ﹤0.01% | 1503 |
|
|
2024
Q3 | $295K | Sell |
883
-2,077
| -70% | -$695K | ﹤0.01% | 1578 |
|
|
2024
Q2 | $808K | Sell |
2,960
-690
| -19% | -$188K | 0.01% | 1001 |
|
|
2024
Q1 | $1.26M | Buy |
3,650
+367
| +11% | +$127K | 0.02% | 756 |
|
|
2023
Q4 | $1.06M | Buy |
3,283
+1,221
| +59% | +$394K | 0.02% | 593 |
|
|
2023
Q3 | $739K | Buy |
2,062
+1,459
| +242% | +$523K | 0.02% | 654 |
|
|
2023
Q2 | $229K | Sell |
603
-1,349
| -69% | -$512K | 0.01% | 1155 |
|
|
2023
Q1 | $935K | Buy |
1,952
+586
| +43% | +$281K | 0.03% | 521 |
|
|
2022
Q4 | $574K | Buy |
1,366
+10
| +0.7% | +$4.2K | 0.02% | 622 |
|
|
2022
Q3 | $566K | Buy |
1,356
+31
| +2% | +$12.9K | 0.02% | 529 |
|
|
2022
Q2 | $656K | Buy |
1,325
+123
| +10% | +$60.9K | 0.02% | 509 |
|
|
2022
Q1 | $677K | Sell |
1,202
-77
| -6% | -$43.4K | 0.02% | 559 |
|
|
2021
Q4 | $966K | Buy |
1,279
+125
| +11% | +$94.4K | 0.03% | 418 |
|
|
2021
Q3 | $863K | Buy |
1,154
+693
| +150% | +$518K | 0.03% | 371 |
|
|
2021
Q2 | $297K | Buy |
+461
| New | +$297K | 0.01% | 576 |
|